India Reports 38% Decline in Tuberculosis Mortality Since 2015
National health initiatives and AI-driven diagnostics drive significant progress in tuberculosis control efforts.
1Significant Mortality Decline
India has achieved a 38% reduction in tuberculosis mortality since 2015, surpassing the global average decline of 35%. The country also reports a 94% treatment success rate for drug-susceptible cases. These figures, released in the 2026 WHO Global Tuberculosis Report, highlight the effectiveness of current national health strategies and diagnostic protocols.
2Global Burden Distribution
The South-East Asia region currently records the highest number of new tuberculosis cases globally, accounting for 35% of the total. India alone contributes approximately one-quarter of the global case burden. Alongside Indonesia, the Philippines, China, and Pakistan, these nations represent the majority of the world's new tuberculosis infections reported last year.
3Technological Diagnostic Integration
The National TB Elimination Programme utilizes advanced AI-enabled X-rays and rapid diagnostic tools to identify cases early. Furthermore, the government employs AI chatbots like Khushi and predictive analytics to map infection hotspots. These digital interventions allow health officials to identify high-risk patients who are prone to adverse outcomes during their treatment.
4Support and Nutritional Initiatives
India's strategy includes the Nikshay Poshan Yojana and Nikshay Mitra initiatives, which provide essential nutritional support to patients. Addressing undernutrition is critical, as it is linked to an estimated 9.6 lakh new cases. By integrating direct medical care with social support, the program aims to mitigate the economic vulnerability of affected households.
5Economic and Social Impact
Globally, 50% of tuberculosis patients face catastrophic costs, defined as exceeding 20% of total household income. These expenses include direct medical fees and indirect losses such as reduced wages. Addressing these financial barriers remains a primary challenge, as economic instability often prevents patients from completing the full course of their prescribed medical treatment.
6Risk Factors and Comorbidities
Compromised immune systems significantly increase the risk of contracting tuberculosis. Major drivers include diabetes, HIV infection, and tobacco use, which collectively account for millions of new cases annually. The report emphasizes that public health efforts must address these underlying health conditions to effectively reduce the transmission of the infectious bacterial agent.
7The MDR-TB Crisis
Multidrug-resistant tuberculosis remains a severe health security threat, with only two in five affected individuals receiving appropriate treatment globally. While 86 million lives have been saved since 2000, the emergence of resistant strains complicates eradication efforts. Strengthening diagnostic infrastructure is essential to ensure that patients receive the correct medication from the start.
8Future Outlook and Progress
Between December 2024 and November 2026, the TB Mukt Bharat Abhiyaan successfully screened over 25 crore individuals. This massive outreach demonstrates the scale of India's commitment to eliminating the disease. Future success depends on maintaining these proactive screening levels while continuing to address the social determinants that facilitate the spread of infection.